Statin Reduced Risk of Heart Disease in People With HIV
BRISBANE, Australia — The cholesterol-lowering agent pitavastatin (Livalo) as primary prevention reduced the risk of major adverse cardiovascular events (MACE) among people living with HIV, the randomized REPRIEVE trial showed. Over a median follow-up of about 5 years, incidence of any MACE was 35% lower in the pitavastatin group compared with a placebo group, at […]